CATALOGO DEI PRODOTTI DELLA RICERCA

PANUNZIO, ANDREA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.186
NA - Nord America 1.515
AS - Asia 1.405
SA - Sud America 287
AF - Africa 97
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.495
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.452
RU - Federazione Russa 1.309
SG - Singapore 598
CN - Cina 304
IT - Italia 279
BR - Brasile 250
HK - Hong Kong 191
VN - Vietnam 114
GB - Regno Unito 92
FI - Finlandia 82
DE - Germania 78
IE - Irlanda 69
SE - Svezia 68
NL - Olanda 63
KR - Corea 57
FR - Francia 43
TG - Togo 42
CA - Canada 38
PL - Polonia 22
ES - Italia 21
BJ - Benin 20
IN - India 20
TR - Turchia 20
JP - Giappone 18
LT - Lituania 16
MX - Messico 14
AT - Austria 13
IQ - Iraq 12
AR - Argentina 10
BD - Bangladesh 10
ZA - Sudafrica 10
BE - Belgio 9
ID - Indonesia 8
MA - Marocco 7
PK - Pakistan 7
UZ - Uzbekistan 7
VE - Venezuela 7
TN - Tunisia 6
UA - Ucraina 6
CO - Colombia 5
EC - Ecuador 5
EG - Egitto 5
KE - Kenya 5
AZ - Azerbaigian 4
JO - Giordania 4
KG - Kirghizistan 4
PY - Paraguay 4
AE - Emirati Arabi Uniti 3
BO - Bolivia 3
CY - Cipro 3
CZ - Repubblica Ceca 3
HN - Honduras 3
IL - Israele 3
AU - Australia 2
BG - Bulgaria 2
CR - Costa Rica 2
ET - Etiopia 2
LA - Repubblica Popolare Democratica del Laos 2
LV - Lettonia 2
PH - Filippine 2
PT - Portogallo 2
SA - Arabia Saudita 2
TH - Thailandia 2
TW - Taiwan 2
UY - Uruguay 2
AL - Albania 1
BN - Brunei Darussalam 1
CH - Svizzera 1
CL - Cile 1
CU - Cuba 1
CW - ???statistics.table.value.countryCode.CW??? 1
DO - Repubblica Dominicana 1
GP - Guadalupe 1
GR - Grecia 1
HU - Ungheria 1
IM - Isola di Man 1
IR - Iran 1
KZ - Kazakistan 1
LB - Libano 1
MK - Macedonia 1
MY - Malesia 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PW - Palau 1
SV - El Salvador 1
TT - Trinidad e Tobago 1
YE - Yemen 1
Totale 5.495
Salva come PNG Salva come JPEG
Città #
Moscow 474
Singapore 330
Dallas 253
Ashburn 216
Hong Kong 188
New York 96
Beijing 95
Los Angeles 86
Chandler 83
Dublin 69
The Dalles 53
Helsinki 49
Ho Chi Minh City 42
Lomé 42
Verona 39
Milan 31
Hanoi 30
London 29
São Paulo 26
Munich 25
Amsterdam 23
Redondo Beach 23
Buffalo 22
Santa Clara 22
Turku 21
Cotonou 20
Boardman 19
Frankfurt am Main 19
Seattle 19
Orem 18
Brooklyn 17
Rome 17
Montreal 16
Stockholm 16
Warsaw 16
Columbus 14
Chicago 12
Phoenix 12
Southend 12
Tokyo 12
Atlanta 11
Lappeenranta 11
Houston 10
Poplar 10
Bari 9
Brussels 9
Jacksonville 9
Johannesburg 9
Toronto 9
Denver 8
Lawrence 8
Manchester 8
Princeton 8
Belo Horizonte 7
Chennai 7
Redmond 7
Rio de Janeiro 7
San Francisco 7
Ankara 6
Bologna 6
Falkenstein 6
Guangzhou 6
Jinan 6
Nuremberg 6
Ottawa 6
Palermo 6
Roubaix 6
Tashkent 6
Washington 6
Wilmington 6
Ann Arbor 5
Isola della Scala 5
Mumbai 5
Sindelfingen 5
Amman 4
Baghdad 4
Baku 4
Bexley 4
Bishkek 4
Cairo 4
Dongguan 4
Goiânia 4
Grezzana 4
Istanbul 4
Nairobi 4
Porto Alegre 4
Querétaro 4
Seoul 4
São Bernardo do Campo 4
Vienna 4
Bauru 3
Boston 3
Bình Dương 3
Bắc Ninh 3
Casablanca 3
Caxias do Sul 3
Charleston 3
Charlotte 3
Curitiba 3
Da Nang 3
Totale 2.946
Salva come PNG Salva come JPEG
Nome #
The 2012 Briganti nomogram predicts disease progression in surgically treated intermediate-risk prostate cancer patients with favorable tumor grade group eventually associated with some adverse factors 240
Abdominal-aortic atherosclerotic plaque index and perioperative outcomes in partial nephrectomy 177
Advanced age is an independent prognostic factor of disease progression in high-risk prostate cancer: results in 180 patients treated with robot-assisted radical prostatectomy and extended pelvic lymph node dissection in a tertiary referral center 157
Endogenous testosterone density predicts unfavorable disease at final pathology in intermediate risk prostate cancer 157
Advanced age portends poorer prognosis after radical prostatectomy: a single center experience 156
Positive Association between Basal Total Testosterone Circulating Levels and Tumor Grade Groups at the Time of Diagnosis of Prostate Cancer 137
Endogenous testosterone density is an independent predictor of pelvic lymph node invasion in high-risk prostate cancer: results in 201 consecutive patients treated with radical prostatectomy and extended pelvic lymph node dissection 137
The Influence of Endogenous Testosterone Density on Unfavorable Disease and Tumor Load at Final Pathology in Intermediate-Risk Prostate Cancer: Results in 338 Patients Treated with Radical Prostatectomy and Extended Pelvic Lymph Node Dissection 136
Prognostic Impact and Clinical Implications of Unfavorable Upgrading in Low-Risk Prostate Cancer after Robot-Assisted Radical Prostatectomy: Results of a Single Tertiary Referral Center 130
Preoperative endogenous testosterone density predicts disease progression from localized impalpable prostate cancer presenting with PSA levels elevated up to 10 ng/mL 129
Searching the half-full glass of COVID-19 pandemic: basic hygienic measures positively impact on postoperative infections after major elective urological surgery: a single-center matched pair analysis 127
Open approach, extended pelvic lymph node dissection, and seminal vesicle invasion are independent predictors of hospital readmission after prostate cancer surgery: A large retrospective study 127
Preoperative endogenous total testosterone predicts prostate cancer progression: results in 580 consecutive patients treated with robot assisted radical prostatectomy for clinically localized disease 126
The impact of extended pelvic lymph node dissection on the risk of hospital readmission within 180 days after robot assisted radical prostatectomy 126
Incidental prostate cancer after transurethral resection of the prostate: analysis of incidence and risk factors in 458 patients 126
AB0 blood groups and oncological and functional outcomes in bladder cancer patients treated with radical cystectomy 123
American Society of Anesthesiologists (ASA) physical status system predicts the risk of postoperative Clavien-Dindo complications greater than one at 90 days after robot-assisted radical prostatectomy: final results of a tertiary referral center 121
Prostate Volume Index Is Able to Differentiate between Prostatic Chronic Inflammation and Prostate Cancer in Patients with Normal Digital Rectal Examination and Prostate-Specific Antigen Values <10 ng/mL: Results of 564 Biopsy Naïve Cases 115
Clinical implications of endogenous testosterone density on prostate cancer progression in patients with very favorable low and intermediate risk treated with radical prostatectomy 110
Gender-specific counselling of patients with upper tract urothelial carcinoma and Lynch syndrome 109
Normal preoperative endogenous testosterone levels predict prostate cancer progression in elderly patients after radical prostatectomy 109
Impairment in Activities of Daily Living Assessed by the Barthel Index Predicts Adverse Oncological Outcomes After Radical Cystectomy for Bladder Cancer 108
Impact of functional impairment and cognitive status on perioperative outcomes and costs after radical cystectomy: The role of Barthel Index 102
Accuracy of the CUETO, EORTC 2016 and EAU 2021 scoring models and risk stratification tables to predict outcomes in high-grade non-muscle-invasive urothelial bladder cancer 100
Omics in urology: An overview on concepts, current status and future perspectives 100
Endogenous testosterone density associates with predictors of tumor upgrading and disease progression in the low through favorable intermediate prostate cancer risk categories: analysis of risk factors and clinical implications 97
Changes in renal function after nephroureterectomy for upper urinary tract carcinoma: analysis of a large multicenter cohort (Radical Nephroureterectomy Outcomes (RaNeO) Research Consortium) 93
Botulinum Toxin-A Injection in Chronic Pelvic Pain Syndrome Treatment: A Systematic Review and Pooled Meta-Analysis 92
Transperineal Laser Ablation for Benign Prostatic Enlargement: A Systematic Review and Pooled Analysis of Pilot Studies 90
Cancer-specific Mortality After Cryoablation vs Heat-based Thermal Ablation in T1a Renal Cell Carcinoma 89
Cancer-specific mortality free survival rates in non-metastatic non-clear cell renal carcinoma patients at intermediate/high risk of recurrence 86
Tumor upgrading among very favorable intermediate-risk prostate cancer patients treated with robot-assisted radical prostatectomy: how can it impact the clinical course? 85
The Impact of Baseline Endogenous Testosterone Levels on Risk Stratification in Pathological Organ-Confined Prostate Cancer: Results in 460 Patients Treated with Robot-Assisted Radical Prostatectomy 83
Age represents the main driver of surgical decision making in patients candidate to radical cystectomy 81
African American vs Caucasian race/ethnicity in adrenocortical carcinoma patients 78
Racial/ethnic disparities in the distribution and effect of type and number of high-risk criteria on mortality in prostate cancer patients treated with radiotherapy 78
Severe systemic disease of the American Society of Anesthesiologists' (ASA) physical status system classification associated with delayed length of hospital stay in 1329 consecutive patients treated with radical prostatectomy for clinical prostate cancer 75
Prognostic Impact and Clinical Implications of Adverse Tumor Grade in Very Favorable Low- and Intermediate-Risk Prostate Cancer Patients Treated with Robot-Assisted Radical Prostatectomy: Experience of a Single Tertiary Referral Center 75
Contemporary conditional cancer-specific survival rates in surgically treated adrenocortical carcinoma patients: A stage-specific analysis 73
Differences in Cancer-Specific Mortality after Trimodal Therapy for T2N0M0 Bladder Cancer according to Histological Subtype 73
Cancer specific mortality in patients with collecting duct vs. clear cell renal carcinoma 70
Conditional survival after radical cystectomy for non-metastatic muscle-invasive squamous cell carcinoma of the urinary bladder: A population-based analysis 70
Effect of inguinal lymph node dissection in lymph node negative patients with squamous cell carcinoma of the penis 69
Collecting duct carcinoma: Epidemiology, clinical characteristics and survival 69
Radical cystectomy in non-metastatic sarcomatoid bladder cancer: A direct comparison vs urothelial bladder cancer 68
Differences in overall survival between clear cell metastatic renal cell carcinoma patients versus population-based controls according to race/ethnicity in the United States 63
Effect of positive surgical margins at radical prostatectomy on cancer-specific mortality in high/very high-risk prostate cancer patients with Gleason Grade Group 4-5 58
The effect of chemotherapy in sarcomatoid bladder cancer patients treated with radical cystectomy 57
Differences in overall survival of T2N0M0 bladder cancer patients vs. population-based controls according to treatment modalities 57
Regional differences in total hospital costs for radical cystectomy in the United States 55
Mortality According to Treatment in Metastatic Collecting Duct Renal Cell Carcinoma 53
MRI-Derived Apparent Diffusion Coefficient of Peri-Prostatic Adipose Tissue Is a Potential Determinant of Prostate Cancer Aggressiveness in Preoperative Setting: A Preliminary Report 51
The association of type and number of high-risk criteria with cancer-specific mortality in prostate cancer patients treated with radical prostatectomy 48
Survival of Testicular Pure Embryonal Carcinoma vs. Mixed Germ Cell Tumor Patients across All Stages 48
Index Cancer Density Is a Stronger Predictor of Pelvic Lymph Node Invasion than Percentage of Biopsy-Positive Cores in EAU High-Risk Prostate Cancer: Clinical Impact in 254 Patients Treated and Staged with Robot-Assisted Radical Prostatectomy 48
Differences in Survival of Clear Cell Metastatic Renal Cell Carcinoma According to Partial vs. Radical Cytoreductive Nephrectomy 46
Hispanic vs. Caucasian Race/Ethnicity in Adrenocortical Carcinoma Patients 41
Survival of Testicular Pure Teratoma vs. Mixed Germ Cell Tumor Patients in Primary Tumor Specimens across All Stages 40
Effect of race/ethnicity on survival in surgically treated intermediate/high risk non-metastatic clear cell renal carcinoma 34
Regional differences in stage distribution and rates of treatment for adrenocortical carcinoma across United States SEER registries 12
Totale 5.590
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.914
article - articoli 23.914
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.828
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20217 0 0 0 0 0 4 0 0 0 0 3 0
2021/202272 4 9 1 11 5 1 3 7 2 2 12 15
2022/2023382 13 24 15 45 30 85 25 53 42 5 25 20
2023/2024618 29 41 52 71 42 92 42 25 6 73 74 71
2024/20251.459 75 59 138 194 66 75 117 107 134 119 117 258
2025/20262.987 260 208 264 765 1.225 265 0 0 0 0 0 0
Totale 5.590